Pharma Mar SA Financial Overview
Pharma Mar SA's market cap is currently $1.61B. The company's EPS TTM is $-0.15213601000000002; its P/E ratio is 42.57; and it has a dividend yield of 1.04%. Pharma Mar SA is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $1.77. See an overview of income statement, balance sheet, and cash flow financials.
